BCRX Financial Facts

Net loss: -18.14M
Loss from operations: -17.19M
See Full Income Statement

Accumulated deficit: -510.92M
Interest payable: 6.75M
See Full Balance Sheet

BioCryst Pharmaceuticals, Inc. (BCRX) Earnings

  |   Expand Research on BCRX
Next EPS Date 5/5/16 EPS Growth Rate -9.5%
Average EPS % Beat Rate +37.9% Revenue Growth Rate -20.3%
Average % Move 1-Wk after EPS -5.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/5/16 Q116 N/A-$0.23 N/A N/A$5.42M N/A N/A N/A
2/23/16 Q415 -$0.25-$0.26 +$0.01$4.6M$6.34M N/A Details
11/5/15 Q315 -$0.20-$0.20 $0.00$11M$6.77M N/A Details
8/7/15 Q215 $0.07-$0.22 +$0.29$25.8M$7.1M N/A Details
5/8/15 Q115 -$0.21-$0.25 +$0.04$6.8M$4.3M N/A Details
2/18/15 Q414 -$0.16-$0.21 +$0.05$5.4M$3.64M N/A Details
11/6/14 Q314 -$0.12-$0.20 +$0.08$3.2M$2.11M N/A Details
8/5/14 Q214 -$0.23-$0.19 -$0.04$1.5M$2.32M N/A Details